Torunn Bruland
Overview
Explore the profile of Torunn Bruland including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
36
Citations
433
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sridhar A, Bakke I, Gopalakrishnan S, Osoble N, Hammarqvist E, Pettersen H, et al.
Sci Rep
. 2025 Jan;
15(1):3753.
PMID: 39885201
Restoration of the intestinal epithelial barrier is crucial for achieving mucosal healing, the therapeutic goal for inflammatory bowel disease (IBD). During homeostasis, epithelial renewal is maintained by crypt stem cells...
2.
Saeterstad S, Ostvik A, Hansen M, Bruland T, Granlund A
J Transl Med
. 2024 Sep;
22(1):849.
PMID: 39304925
No abstract available.
3.
Saeterstad S, Ostvik A, Hansen M, Bruland T, Granlund A
J Transl Med
. 2024 Aug;
22(1):750.
PMID: 39123229
Background: ERAP2 is an aminopeptidase involved in antigen processing and presentation, and harbor genetic variants linked to several inflammatory diseases such as Inflammatory Bowel Disease (IBD). The lack of an...
4.
Catalan-Serra I, Thorsvik S, Beisvag V, Bruland T, Underhill D, Sandvik A, et al.
Inflamm Bowel Dis
. 2023 Dec;
30(7):1164-1177.
PMID: 38103028
Background: There is growing evidence of the role of the mycobiome in inflammatory bowel disease (IBD). Variations within phenotypes and activity and with prognosis have been poorly studied. Methods: A...
5.
Gopalakrishnan S, Bakke I, Hansen M, Skovdahl H, Granlund A, Sandvik A, et al.
Front Immunol
. 2023 Mar;
14:1097383.
PMID: 36911731
There are many unanswered questions regarding responses to proinflammatory signals in intestinal epithelial cells (IECs). For example, chemokines secreted by IECs upon external stimuli play multifunctional roles in both homeostasis...
6.
Walaas G, Gopalakrishnan S, Bakke I, Skovdahl H, Flatberg A, Ostvik A, et al.
Front Immunol
. 2023 Feb;
14:1095812.
PMID: 36793710
Background: The epithelium in the colonic mucosa is implicated in the pathophysiology of various diseases, including inflammatory bowel diseases and colorectal cancer. Intestinal epithelial organoids from the colon (colonoids) can...
7.
Gopalakrishnan S, Hansen M, Skovdahl H, Roseth I, Granlund A, Ostvik A, et al.
Front Immunol
. 2022 Jun;
13:882277.
PMID: 35655783
Major Histocompatibility Complex (MHC)-I and -II genes are upregulated in intestinal epithelial cells (IECs) during active inflammatory bowel diseases (IBD), but little is known about how IBD-relevant pro-inflammatory signals and...
8.
Bruland T, Ostvik A, Sandvik A, Hansen M
Int J Mol Sci
. 2021 Oct;
22(19).
PMID: 34639191
Ulcerative colitis is characterized by relapsing and remitting colonic mucosal inflammation. During the early stages of viral infection, innate immune defenses are activated, leading to the rapid release of cytokines...
9.
Bakke I, Walaas G, Bruland T, Royset E, Granlund A, Escudero-Hernandez C, et al.
J Gastroenterol
. 2021 Aug;
56(10):914-927.
PMID: 34414506
Background: Collagenous colitis (CC) is an inflammatory bowel disease where chronic diarrhoea is the main symptom. Diagnostic markers distinguishing between CC and other causes of chronic diarrhoea remain elusive. This...
10.
Skovdahl H, Gopalakrishnan S, Svendsen T, Granlund A, Bakke I, Ginbot Z, et al.
Front Pharmacol
. 2021 May;
12:679741.
PMID: 34054553
Treatment of inflammatory bowel disease (IBD) is challenging, with a series of available drugs each helping only a fraction of patients. Patients may face time-consuming drug trials while the disease...